Your browser doesn't support javascript.
loading
Design of novel granulopoietic proteins by topological rescaffolding.
Hernandez Alvarez, Birte; Skokowa, Julia; Coles, Murray; Mir, Perihan; Nasri, Masoud; Maksymenko, Kateryna; Weidmann, Laura; Rogers, Katherine W; Welte, Karl; Lupas, Andrei N; Müller, Patrick; ElGamacy, Mohammad.
Afiliación
  • Hernandez Alvarez B; Max Planck Institute for Developmental Biology, Tübingen, Germany.
  • Skokowa J; University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany.
  • Coles M; Max Planck Institute for Developmental Biology, Tübingen, Germany.
  • Mir P; University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany.
  • Nasri M; University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany.
  • Maksymenko K; Friedrich Miescher Laboratory of the Max Planck Society Tübingen, Germany.
  • Weidmann L; Max Planck Institute for Developmental Biology, Tübingen, Germany.
  • Rogers KW; Friedrich Miescher Laboratory of the Max Planck Society Tübingen, Germany.
  • Welte K; University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany.
  • Lupas AN; Max Planck Institute for Developmental Biology, Tübingen, Germany.
  • Müller P; University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany.
  • ElGamacy M; Friedrich Miescher Laboratory of the Max Planck Society Tübingen, Germany.
PLoS Biol ; 18(12): e3000919, 2020 12.
Article en En | MEDLINE | ID: mdl-33351791
ABSTRACT
Computational protein design is rapidly becoming more powerful, and improving the accuracy of computational methods would greatly streamline protein engineering by eliminating the need for empirical optimization in the laboratory. In this work, we set out to design novel granulopoietic agents using a rescaffolding strategy with the goal of achieving simpler and more stable proteins. All of the 4 experimentally tested designs were folded, monomeric, and stable, while the 2 determined structures agreed with the design models within less than 2.5 Å. Despite the lack of significant topological or sequence similarity to their natural granulopoietic counterpart, 2 designs bound to the granulocyte colony-stimulating factor (G-CSF) receptor and exhibited potent, but delayed, in vitro proliferative activity in a G-CSF-dependent cell line. Interestingly, the designs also induced proliferation and differentiation of primary human hematopoietic stem cells into mature granulocytes, highlighting the utility of our approach to develop highly active therapeutic leads purely based on computational design.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Ingeniería de Proteínas / Granulocitos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS Biol Asunto de la revista: BIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Asunto principal: Ingeniería de Proteínas / Granulocitos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS Biol Asunto de la revista: BIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania